Federated Hermes’s Altimmune ALT Stock Holding History

Federated Hermes’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31K	Buy	+760	New	+$2.27K	﹤0.01%	1984
2025 Q4	–	Sell	-75	Closed	-$283	–	2071
2025 Q3	$283	Sell	75 -915,383	-100%	-$3.53M	﹤0.01%	2104
2025 Q2	$3.54M	Buy	915,458 +727,731	+388%	+$3.94M	0.01%	813
2025 Q1	$939K	Buy	+187,727	New	+$1.19M	﹤0.01%	1122
2024 Q1	–	Sell	-121	Closed	-$1.36K	–	2028
2023 Q4	$1.36K	Sell	121 -2,014	-94%	-$8.41K	﹤0.01%	1954
2023 Q3	$5.55K	Buy	2,135 +1,927	+926%	+$5.53K	﹤0.01%	1875
2023 Q2	$734	Sell	208 -732	-78%	-$3.29K	﹤0.01%	2037
2023 Q1	$3.97K	Buy	+940	New	+$11.2K	﹤0.01%	1953
2020 Q1	–	Sell	-370	Closed	-$1K	–	2237
2019 Q4	$1K	Buy	370 +223	+152%	+$412	﹤0.01%	2062
2019 Q3	$1K	Buy	+147	New	+$326	﹤0.01%	2067

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's ALT Position: Q2 2026 in Review

Federated Hermes opened a new position in Altimmune (ALT) in Q2 2026: 760 shares worth $2.31K. The stake represents ﹤0.01% of the portfolio and ranks #1984 among its holdings. This is a return to the name: Federated Hermes previously reported a position in ALT as recently as Q3 2025.

Federated Hermes first reported a position in ALT in Q3 2019 and has held it in 10 quarters since. The position peaked at $3.54M in Q2 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Federated Hermes held 760 shares of Altimmune worth $2.31K as of Q2 2026.
Altimmune was a new Federated Hermes position in Q2 2026.
Altimmune made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1984 holding.
Federated Hermes first reported a position in Altimmune in Q3 2019 and has held it in 10 quarters since.
Federated Hermes's Altimmune position peaked at $3.54M in Q2 2025.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.